Latest News
Abbott Expands Agreement with GSK to Include Development of a Companion Diagnostic Test
News Nov 29, 2011Companion diagnostic tests identify specific DNA sequences for cancer immunotherapy antigen.
READ MORE
Informatics Student Implements Real World Cancer Research
News Nov 29, 2011Alexis Christoforides, a first year Ph.D. candidate at Arizona State University’s Department of Biomedical Informatics, and full-time employee at the Translational Genomics Institute (TGen), renders class work to real world application.
READ MORE
Cancer stem cells: Prime targets in the war against cancer
News Nov 28, 2011Scientists now believe that only a small subset of cells in a tumour has the ability to self-renew and differentiate indefinitely into other cells – these are known as cancer stem cells (CSC) due to their stem-like qualities.
READ MORE
UT Southwestern Team Identifies Tumor-specific Pathway
News Nov 28, 2011Finding could lead to new cancer-stopping therapies.
READ MORE
Horizon Announces Collaboration with NCI and NHGRI
News Nov 24, 2011Horizon’s rAAV gene targeting to be applied in cancer research programs, enabling the NCI and NHGRI to engineer human isogenic disease models.
READ MORE
Geron to Focus on its Novel Cancer Programs
News Nov 21, 2011Geron Corporation has announced that they will be focusing on first-in-class oncology programs. As a consequence, the Company will discontinue further development of its stem cell programs and is seeking partners for these novel assets.
READ MORE
Key Patents Issued to Celerus Diagnostics
News Nov 21, 2011Company Secures Long-term Control of Rapid IHC® Technologies
READ MORE
High-Throughput Targeted Sequencing of Cancer Predisposition Genes
News Nov 18, 2011British Columbia Cancer Agency selects Raindance’s new ThunderStorm System to aid researchers in hereditary cancer testing, using next-generation sequencing.
READ MORE
MethylGene Reports Clinical Data for MGCD265
News Nov 17, 2011Data to be presented at the 2011 AACR-NCI- EORTC Molecular Targets and Cancer Therapeutics Conference.
READ MORE
Stage II Colon Cancer Recurrence Signature Published in the Journal of Clinical Oncology
News Nov 15, 2011The article entitled “Development and Independent Validation of a Prognostic Assay for Stage II Colon Cancer Using Formalin-Fixed Paraffin-Embedded Tissue” gives detail on the development and validation of a prognostic gene signature in Stage II colon cancer.
READ MORE
